Department of Urology, Daping Hospital, Army Medical University, Chongqing, China.
Department of Gastrointestinal Surgery, Hubei Cancer Hospital, Tongji Medical College, University of Science and Technology, Huazhong, China.
Sci Rep. 2019 Mar 22;9(1):5018. doi: 10.1038/s41598-019-41123-2.
To investigate the surgical outcomes of vesiculoscopy on refractory hematospermia and ejaculatory duct obstruction (EDO), the clinical data (including pelvic magnetic resonance imaging (MRI) examinations and the long-term effects of endoscopic treatment) from 305 patients were analyzed. Four main etiologic groups were found on MRI. We found that 62.0% (189/305) of patients showed abnormal signal intensity in MRI investigations in the seminal vesicle (SV) area. Cystic lesions were observed in 36.7% (112/305) of the patients. The third sign was dilatation or enlargement of unilateral or bilateral SV, which were observed in 32.1% (98/305) of the patients. The fourth sign was stone formation in SV or in an adjacent cyst, which was present in 8.5% (26/305) of the patients. The transurethral endoscopy or seminal vesiculoscopy and the related procedures, including fenestration in prostatic utricle (PU), irrigation, lithotripsy, stone removal, biopsy, electroexcision, fulguration, or transurethral resection/incision of the ejaculatory duct (TURED/TUIED), chosen according to the different situations of individual patients were successfully performed in 296 patients. Fenestrations in PU+ seminal vesiculoscopy were performed in 66.6% (197/296) of cases. Seminal vesiculoscopy via the pathological opening in PU was performed in 10.8% (32/296) of cases. TURED/TUIED + seminal vesiculoscopy was performed in 12.8% (38/296) of cases, and seminal vesiculoscopy by the natural orifices of the ejaculatory duct (ED) was performed in 2.4% (7/296) of cases. Electroexcision and fulguration to the abnormal blood vessels or cavernous hemangioma at posterior urethra were performed in 7.4% (22/296) of cases. Two hundred and seventy-one patients were followed up for 6-72 months. The hematospermia of all the patients disappeared within 2-6 weeks, and 93.0% of the patients showed no further hematospermia during follow-up. No obvious postoperative complications were observed. The transurethral seminal vesiculoscopy technique and related procedures are safe and effective approaches for refractory hematospermia and EDO.
为了研究精囊镜治疗难治性血精症和射精管梗阻(EDO)的手术效果,分析了 305 例患者的临床资料(包括盆腔磁共振成像(MRI)检查和内镜治疗的长期效果)。在 MRI 上发现了 4 个主要病因组。我们发现 62.0%(189/305)的患者在精囊(SV)区 MRI 检查中显示异常信号强度。36.7%(112/305)的患者有囊性病变。第三个征象是单侧或双侧 SV 扩张或增大,32.1%(98/305)的患者有此征象。第四个征象是 SV 或邻近囊肿内的结石形成,8.5%(26/305)的患者有此征象。根据患者的不同情况,选择经尿道内镜或精囊镜及相关手术,包括前列腺囊开窗术(PU)、冲洗、碎石、取石、活检、电切、电灼或经尿道射精管切除术/切开术(TURED/TUIED),在 296 例患者中成功完成。PU+精囊镜开窗术在 66.6%(197/296)的病例中进行。经 PU 病理开口行精囊镜检查 10.8%(32/296)。TURED/TUIED+精囊镜检查 12.8%(38/296),经射精管自然开口行精囊镜检查 2.4%(7/296)。经尿道电切和电灼后尿道异常血管或海绵状血管瘤 7.4%(22/296)。271 例患者随访 6-72 个月。所有患者的血精均在 2-6 周内消失,93.0%的患者随访期间无进一步血精。未观察到明显的术后并发症。经尿道精囊镜技术及相关手术是治疗难治性血精症和 EDO 的安全有效方法。